124 related articles for article (PubMed ID: 15592974)
1. [Tumour markers].
Lamerz R; Stieber P
Dtsch Med Wochenschr; 2004 Dec; 129(50):2722-30. PubMed ID: 15592974
[No Abstract] [Full Text] [Related]
2. [Significance of carcinoembryonic antigen in the follow up of colorectal cancer].
Sanz Rubiales A; García Alvarez G
Med Clin (Barc); 1998 Feb; 110(7):277-8. PubMed ID: 9562956
[No Abstract] [Full Text] [Related]
3. Use of multiple markers to enhance clinical utility.
Mercer DW
Immunol Ser; 1990; 53():39-54. PubMed ID: 2100569
[No Abstract] [Full Text] [Related]
4. Postoperative evaluation of patients with colorectal cancer.
Nelson RL
Semin Oncol; 1995 Oct; 22(5):488-93. PubMed ID: 7570059
[No Abstract] [Full Text] [Related]
5. The follow-up of the cancer patient.
Pettavel J
Aktuelle Probl Chir; 1970; 14():213-35. PubMed ID: 4146419
[No Abstract] [Full Text] [Related]
6. Clinical practice. Surveillance strategies after curative treatment of colorectal cancer.
Pfister DG; Benson AB; Somerfield MR
N Engl J Med; 2004 Jun; 350(23):2375-82. PubMed ID: 15175439
[No Abstract] [Full Text] [Related]
7. Follow-up for patients with colorectal cancer after curative-intent primary treatment.
Johnson FE; Virgo KS; Fossati R
J Clin Oncol; 2004 Apr; 22(8):1363-5. PubMed ID: 15007083
[No Abstract] [Full Text] [Related]
8. Can intra-operative intraperitoneal free cancer cell detection techniques identify patients at higher recurrence risk following curative colorectal cancer resection: a meta-analysis.
Rekhraj S; Aziz O; Prabhudesai S; Zacharakis E; Mohr F; Athanasiou T; Darzi A; Ziprin P
Ann Surg Oncol; 2008 Jan; 15(1):60-8. PubMed ID: 17909914
[TBL] [Abstract][Full Text] [Related]
9. Once more confirmed: adjuvant radiotherapy and improved local control provide a significant survival benefit for early breast cancer patients.
Sautter-Bihl ML; Sauer R
Strahlenther Onkol; 2006 Apr; 182(4):199-201. PubMed ID: 16622620
[No Abstract] [Full Text] [Related]
10. Increased levels of tumor markers in the follow-up of 400 patients with breast cancer without recurrence or metastasis: interpretation of false-positive results.
Zervoudis S; Peitsidis P; Iatrakis G; Panourgias E; Koureas A; Navrozoglou I; Dubois JB
J BUON; 2007; 12(4):487-92. PubMed ID: 18067207
[TBL] [Abstract][Full Text] [Related]
11. The utility of lactate dehydrogenase in the follow-up of testicular germ cell tumours.
Venkitaraman R; Johnson B; Huddart RA; Parker CC; Horwich A; Dearnaley DP
BJU Int; 2007 Jul; 100(1):30-2. PubMed ID: 17552950
[TBL] [Abstract][Full Text] [Related]
12. Follow-up testing after cancer treatment: is it indicated?
Edelman MJ; Siegel D; Meyers F
West J Med; 1998 Jun; 168(6):528-9. PubMed ID: 9656000
[No Abstract] [Full Text] [Related]
13. [For an intensive strategy for surveillance after treatment of breast cancer].
Sebban E
Gynecol Obstet Fertil; 2006 Mar; 34(3):268-70. PubMed ID: 16529970
[No Abstract] [Full Text] [Related]
14. Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells.
Lloyd JM; McIver CM; Stephenson SA; Hewett PJ; Rieger N; Hardingham JE
Clin Cancer Res; 2006 Jan; 12(2):417-23. PubMed ID: 16428481
[TBL] [Abstract][Full Text] [Related]
15. [Follow-up of patients after curative surgery for colorectal cancer].
Wille-Jørgensen PA; Madsen MR
Ugeskr Laeger; 2005 Oct; 167(44):4189-91. PubMed ID: 16266577
[TBL] [Abstract][Full Text] [Related]
16. Circulating mitochondrial DNA in the serum of patients with testicular germ cell cancer as a novel noninvasive diagnostic biomarker.
Ellinger J; Albers P; Müller SC; von Ruecker A; Bastian PJ
BJU Int; 2009 Jul; 104(1):48-52. PubMed ID: 19154496
[TBL] [Abstract][Full Text] [Related]
17. [General and specific laboratory parameters within the scope of tumor after-care in gynecologic malignancies and breast cancer].
Kreienberg R
Gynakologe; 1989 Feb; 22(1):55-62. PubMed ID: 2653979
[No Abstract] [Full Text] [Related]
18. Cognitive impairment, aromatase inhibitors, and age.
Tralongo P; Di Mari A; Ferrau' F
J Clin Oncol; 2005 Jun; 23(18):4243. PubMed ID: 15961782
[No Abstract] [Full Text] [Related]
19. Progressive epithelial ovarian carcinoma. Prognostic factors and clinical management.
Grønlund B
Dan Med Bull; 2006 Aug; 53(3):232-57. PubMed ID: 17092448
[No Abstract] [Full Text] [Related]
20. Monitoring ovarian cancer: CA125 trial stirs controversy.
Chitale R
J Natl Cancer Inst; 2009 Sep; 101(18):1233-5. PubMed ID: 19738165
[No Abstract] [Full Text] [Related]
[Next] [New Search]
